Can a Biobank Take Your Research Further Faster? Find Out.

Identify Your Cohort in Our EMR, DNA and Biospecimen Database of More Than 2.8M Subjects.

More organizations are tapping into biobank capabilities as a way of fueling more efficient and effective research in the development of new drugs and care protocols for a multitude of diseases. But will it work for your research?
Nashville Biosciences provides de-identified biobank and EMR-driven data products to fuel your clinical, pharma, biotech, or AI R&D. Let us run a real-time cohort assessment to see if a biobank approach is a fit for your project. It’s fast, it’s free and you’ll have the answers you need to take the next right step.

Free Real-Time Cohort Assessment

  • This field is for validation purposes and should be left unchanged.

About Us

Nashville Biosciences is leveraging its unique resources and proprietary analytical methods to help improve the prevention, diagnosis and treatment of a wide range of diseases.

Our approach helps to save years of R&D efforts, streamline diagnostic development, prioritize indication and patient subpopulations to improve probability of treatment success, and identify potential side effects sooner to help improve human health.